Passage BIO, Inc. (PASG): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

3.17M
Year ended 2025-12-31
-61.2%
3-year compound annual growth
-39.3%
5-year compound annual growth
54.74M2020-12-31: 38.62M2021-12-31: 53.34M2022-12-31: 54.43M2023-12-31: 54.74M2024-12-31: 3.08M2025-12-31: 3.17M3.17M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-313.17M+3.1%2026-03-03, From 2025-01-01
2024-12-313.08M-94.4%2026-03-03, From 2024-01-01
2023-12-3154.74M+0.6%2025-03-04, From 2023-01-01
2022-12-3154.43M+2.0%2024-03-04, From 2022-01-01
2021-12-3153.34M+38.1%2023-03-06, From 2021-01-01
2020-12-3138.62Mn/a2022-03-03, From 2020-01-01